Abstract

A system of lymphatic vessels has been recently characterized in the meninges, with a postulated role in ‘cleaning’ the brain via cerebral fluid drainage. As meninges are the origin site of migraine pain, we hypothesized that malfunctioning of the lymphatic system should affect the local trigeminal nociception. To test this hypothesis, we studied nociceptive and inflammatory mechanisms in the hemiskull preparations (containing the meninges) of K14-VEGFR3-Ig (K14) mice lacking the meningeal lymphatic system. We recorded the spiking activity of meningeal afferents and estimated the local mast cells population, calcitonin gene-related peptide (CGRP) and cytokine levels as well as the dural trigeminal innervation in freshly-isolated hemiskull preparations from K14-VEGFR3-Ig (K14) or wild type C57BL/6 mice (WT). Spiking activity data have been confirmed in an acquired model of meningeal lymphatic dysfunction (AAV-mVEGFR3(1–4)Ig induced lymphatic ablation). We found that levels of the pro-inflammatory cytokine IL12-p70 and CGRP, implicated in migraine, were reduced in the meninges of K14 mice, while the levels of the mast cell activator MCP-1 were increased. The other migraine-related pro-inflammatory cytokines (basal and stimulated), did not differ between the two genotypes. The patterns of trigeminal innervation in meninges remained unchanged and we did not observe alterations in basal or ATP-induced nociceptive firing in the meningeal afferents associated with meningeal lymphatic dysfunction. In summary, the lack of meningeal lymphatic system is associated with a new balance between pro- and anti-migraine mediators but does not directly trigger meningeal nociceptive state.

Details

Title
The role of the meningeal lymphatic system in local meningeal inflammation and trigeminal nociception
Author
Mikhailov Nikita 1 ; Virenque Anaïs 2 ; Koroleva Kseniia 1 ; Eme-Scolan Elisa 3 ; Teleman Matei 3 ; Abdollahzadeh, Ali 1 ; Giniatullina Raisa 1 ; Gafurov Oleg 4 ; Krivoshein Georgii 1 ; Malm Tarja 1 ; Hämäläinen, Riikka H 1 ; Sierra, Alejandra 1 ; Tohka Jussi 1 ; Rua Rejane 3 ; Noe, Francesco M 2 ; Giniatullin Rashid 1 

 University of Eastern Finland, A. I. Virtanen Institute for Molecular Sciences, Kuopio, Finland (GRID:grid.9668.1) (ISNI:0000 0001 0726 2490) 
 Helsinki University, HiLIFE-Neuroscience Center, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 Centre d’Immunologie de Marseille Luminy, Aix Marseille University, INSERM, CNRS, Marseille, France (GRID:grid.417850.f) (ISNI:0000 0004 0639 5277) 
 Kazan Federal University, Laboratory of Neurobiology, Kazan, Russian Federation (GRID:grid.77268.3c) (ISNI:0000 0004 0543 9688) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2669223220
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.